Glenza 40 mg Capsule

Product Description

Glenza 40 mg Capsule is a targeted treatment for prostate cancer, a disease affecting the male prostate gland responsible for producing seminal fluid. This medication functions as an androgen receptor inhibitor, effectively blocking the action of androgens like testosterone, which play a significant role in the growth and survival of prostate cancer cells. By inhibiting these hormones, Glenza not only slows down the proliferation of cancerous cells but also promotes their death and reduces tumor size. Patients should be aware of potential side effects, including fatigue, hot flashes, and a risk of seizures, making it essential to consult healthcare professionals for appropriate monitoring. Glenza is specifically indicated for use in advanced stages of prostate cancer, particularly in cases resistant to other therapies. This innovative treatment option offers hope for improved outcomes and quality of life for individuals battling this condition. Always discuss with your doctor to ensure Glenza aligns with your treatment goals and to manage any associated risks effectively.